Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Kennedy

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
BMC Bioinformatics|March 21, 2006
Empirical validation of the S-Score algorithm in the analysis of gene expression dataRichard E Kennedy, Kellie J Archer, Michael F Miles
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2013
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's diseaseRichard E Kennedy, Gary R Cutter, Lon S Schneider
Current Alzheimer Research|September 12, 2012
Biomarker positive and negative subjects in the ADNI cohort: clinical characterizationRichard E Kennedy, Lon S Schneider, Gary R Cutter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 4, 2010
Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trialsLon S Schneider, Richard E Kennedy, Gary R Cutter, et al.
Journal of Alzheimer'S Disease : JAD|February 3, 2016
Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical TrialsRichard E Kennedy, Gary R Cutter, Guoqiao Wang, et al.
Psychosomatics|July 2, 2003
Use of the cognitive test for delirium in patients with traumatic brain injuryRichard E Kennedy, Risa Nakase-Thompson, Todd G Nick, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairmentGuoqiao Wang, Richard E Kennedy, Gary R Cutter, et al.
Journal of General Internal Medicine|March 31, 2025
National Norms for Hospital Frailty Risk Score Among Hospitalized Adults in the USAChristine Loyd, Taylor Miller, Shrest Nath, et al.
Brain Injury|July 5, 2002
Stereotypic movement disorder after acquired brain injuryCynthia M McGrath, Richard E Kennedy, Wayne Hoye, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 4, 2016
Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?Richard E Kennedy, Gary R Cutter, Guoqiao Wang, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
BMC Bioinformatics|March 21, 2006
Empirical validation of the S-Score algorithm in the analysis of gene expression dataRichard E Kennedy, Kellie J Archer, Michael F Miles
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2013
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's diseaseRichard E Kennedy, Gary R Cutter, Lon S Schneider
Current Alzheimer Research|September 12, 2012
Biomarker positive and negative subjects in the ADNI cohort: clinical characterizationRichard E Kennedy, Lon S Schneider, Gary R Cutter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 4, 2010
Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trialsLon S Schneider, Richard E Kennedy, Gary R Cutter, et al.
Journal of Alzheimer'S Disease : JAD|February 3, 2016
Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical TrialsRichard E Kennedy, Gary R Cutter, Guoqiao Wang, et al.
Psychosomatics|July 2, 2003
Use of the cognitive test for delirium in patients with traumatic brain injuryRichard E Kennedy, Risa Nakase-Thompson, Todd G Nick, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairmentGuoqiao Wang, Richard E Kennedy, Gary R Cutter, et al.
Journal of General Internal Medicine|March 31, 2025
National Norms for Hospital Frailty Risk Score Among Hospitalized Adults in the USAChristine Loyd, Taylor Miller, Shrest Nath, et al.
Brain Injury|July 5, 2002
Stereotypic movement disorder after acquired brain injuryCynthia M McGrath, Richard E Kennedy, Wayne Hoye, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 4, 2016
Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?Richard E Kennedy, Gary R Cutter, Guoqiao Wang, et al.
Pageof 10